IHH raises claim against Daiichi Sankyo to RM5.7b
IHH Healthcare Bhd said that its wholly owned subsidiary, Northern TK Venture Pte Ltd (NTK), has filed a petition with the Tokyo District Court to increase its damages claim against Japan's Daiichi Sankyo Co Ltd.
The revised claim now amounts to approximately RM5.71 billion, significantly higher than the initial claim of JPY20 billion (RM634 million).
The claim comprises damages arising from NTK's tortious claims (excluding defamation), a separate defamation claim amounting to JPY5 million, and accrued interest.
The move follows NTK's earlier submission of an expert report in February 2025, which quantified losses based on hypothetical scenarios in which NTK's proposed open offers for Fortis Healthcare and Fortis Malar Hospitals had proceeded.
The Tokyo District Court served the petition to Daiichi Sankyo today.
NTK has reserved the right to further amend the claim amount.
The next court hearing is scheduled for July 11, 2025. — TMR
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
29-05-2025
- The Star
IHH revenue grows to RM6.29bil in 1Q25
PETALING JAYA: IHH Healthcare Bhd will be forging ahead with its expansion and growth strategies to meet the increasing demand for quality healthcare services locally and across the region. Following the acquisitions of Timberland Medical Centre in Sarawak and Island Hospital in Penang in 2024, the group said in a Bursa Malaysia filing that it had opened the 127-bed Acibadem Kartal Hospital in Turkiye in the first quarter ended March 31, 2025 (1Q25) and expects to complete the acquisition of the 228-bedded Shrimann Superspeciality Hospital in India during the year. For 1Q25, IHH's net profit dropped to RM514mil from RM768mil in the previous corresponding quarter, while revenue grew to RM6.29bil from RM5.96bil a year earlier. 'The growth in revenue was driven by a sustained demand for quality healthcare services, a case-mix of more acute patients and price adjustments to counter inflation. 'The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue.' IHH said its Singapore hospital inpatient admissions decreased 6% to 14,493 in 1Q25 while its revenue per inpatient admission increased 10% to RM67,294. 'Malaysia's hospital inpatient admissions increased 6% at 62,406 in 1Q25 while its revenue per inpatient admission increased 6% to RM11,334. 'India's hospital inpatient admissions increased 7% to 78,485 in 1Q25 while its revenue per inpatient admission increased 4% to RM10,152.' Meanwhile, Turkiye and Europe hospital inpatient admissions was flat at 66,776 in 1Q25 while its revenue per inpatient admission increased 16% to RM13,522 with price adjustments, especially in Turkiye, to counter hyperinflation. While the demand for quality healthcare remains robust, IHH said ongoing industry-wide challenges including rising cost pressures as well as higher energy costs and staff costs. 'In addition, payor pressures from both public and private insurers continue to shape reimbursement dynamics in the industry.' To unlock value from its key markets and to address the industry-wide challenges, IHH said it has embarked on a multi-year transformation initiative to drive continuous improvement through seven focus areas. The areas are clinical excellence, patient experience, new care models, operational excellence, payor and regulator engagement, employee and doctor value proposition, and the advancement of technology, data, and artificial intelligence. 'The group remains in a good position given its strong track record in delivering high-quality and cost-effective healthcare. 'By leveraging operational synergies across its international network, the group remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare.' Despite global economic and geopolitical headwinds, IHH said it remains well-poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends.
New Straits Times
29-05-2025
- New Straits Times
IHH healthcare Q1 net profit falls to RM514mil
KUALA LUMPUR: IHH Healthcare Bhd has recorded a drop in net profit to RM514 million in the first quarter of its financial year ending Dec 31, 2025 (1Q FY2025) from RM768 million in 1Q FY2024. Revenue for the quarter under review rose to RM6.29 billion from RM5.96 billion last year, due to gains in the hospital and healthcare segments and Parkway Life REIT (PLife REIT), the company said in a filing with Bursa Malaysia. "Hospital and healthcare revenue in 1Q FY2025 increased by 7.0 per cent to RM6.05 billion, driven by sustained demand for quality healthcare services, a case-mix of more acute patients, and price adjustments to counter inflation. "The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue," it said. IHH Healthcare added that PLife REIT's external revenue for 1Q FY2025 rose 15 per cent to RM45 million, driven by contributions from the 11 nursing home properties in France acquired in December 2024. The company remains in a strong position, given its track record in delivering high-quality and cost-effective healthcare. By leveraging operational synergies across its international network, IHH Healthcare remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare. "Despite global economic and geopolitical headwinds, the group remains well poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends," it said
The Star
29-05-2025
- The Star
IHH to forge ahead with expansion and growth strategies
PETALING JAYA: IHH Healthcare Bhd will be forging ahead with its expansion and growth strategies to meet the increasing demand for quality healthcare services locally and across the region. Following the acquisitions of Timberland Medical Centre in Sarawak and Island Hospital in Penang in 2024, the group said in a Bursa Malaysia filing that it had opened the 127-bed Acibadem Kartal Hospital in Turkey in the first quarter of 2025 (1Q25) and expects to complete the acquisition of the 228-bedded Shrimann Superspeciality Hospital in India during the year. For 1Q25 (ended March 31, 2025), IHH's net profit dropped to RM514mil from RM768mil in the previous corresponding quarter, while revenue grew to RM6.29bil from RM5.96bil a year earlier. 'The growth in revenue was driven by a sustained demand for quality healthcare services, a case-mix of more acute patients and price adjustments to counter inflation. 'The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue.' IHH said its Singapore hospital inpatient admissions decreased 6% to 14,493 in Q15 while its revenue per inpatient admission increased 10% to RM67,294. 'Malaysia's hospital inpatient admissions increased 6% at 62,406 in 1Q25 while its revenue per inpatient admission increased 6% to RM11,334. 'India's hospital inpatient admissions increased 7% to 78,485 in 1Q25 while its revenue per inpatient admission increased 4% to RM10,152.' Meanwhile, Turkiye and Europe hospital inpatient admissions was flat at 66,776 in 1Q25 while its revenue per inpatient admission increased 16% to RM13,522 with price adjustments, especially in Turkiye, to counter hyperinflation. While the demand for quality healthcare remains robust, IHH said ongoing industry-wide challenges including rising cost pressures as well as higher energy costs and staff costs. 'In addition, payor pressures from both public and private insurers continue to shape reimbursement dynamics in the industry.' To unlock value from its key markets and to address the industry-wide challenges, IHH said it has embarked on a multi-year transformation initiative to drive continuous improvement through seven focus areas - clinical excellence, patient experience, new care models, operational excellence, payor and regulator engagement, employee and doctor value proposition, and the advancement of technology, data, and artificial intelligence. 'The group remains in a good position given its strong track record in delivering high-quality and cost-effective healthcare. 'By leveraging operational synergies across its international network, the group remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare.' Despite global economic and geopolitical headwinds, IHH said it remains well-poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends.
